Moderna Class Action Lawsuit: The Truth Begins to Emanate

INTRODUCTION TO THE MODERNA CLASs ACTION LAWSUIT

Give Timothy L. Miles a call for a free case evaluation to discuss your options in Moderna class action lawsuit

The Moderna class action lawsuit seeks to represent purchasers or acquirers of Moderna, Inc. (NASDAQ: MRNA) publicly traded securities between January 18, 2023 and June 25, 2024, inclusive (the “Class Period”).  Captioned Wentz v. Moderna, Inc., No. 24-cv-12058 (D. Mass.), the Moderna class action lawsuit charges Moderna and certain of Moderna’s top executives with violations of the Securities Exchange Act of 1934.

If you have suffered losses in Moderna stock and are interested in becoming the lead plaintiff in the Moderna lawsuit or have any inquiries regarding your rights as a shareholder, please reach out to Moderna Stock Loss Lawyer Timothy L. Miles at no cost. You can contact him by calling 855/846-6529, sending an e-mail to [email protected], or filling out a contact form. Lead plaintiff motions for the Moderna class action lawsuit must be filed with the court no later than October 8, 2024.

---

the allegations in the Moderna CLASS ACTION lawsuit

​Moderna is a biotechnology company that discovers, develops, and commercializes messenger RNA (“mRNA”) therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases. The Moderna class action lawsuit can be summarized as follows:
​July 23, 2023:

• Moderna initiated a rolling submission of a Biologics License Application (“BLA”) to the U.S. Food and Drug Administration (“FDA”) for real-time review of mRESVIA (“mRNA-1345”).​

May 31, 2024:

• Moderna indicated a vaccine efficacy for mRNA-1345 of only 78.7%, significantly lower than the 83.7% vaccine efficacy that Moderna had previously identified in its mRNA-1345 BLA rolling submission to the FDA.  On this news, the price of Moderna stock fell nearly 6%, according to the complaint.

June 26, 2024:

• Moderna disclosed that after 18 months, mRNA-1345 proved only 49.9% to 50.3% effective against multiple symptoms of lower respiratory tract disease – a significantly lower efficacy rate than vaccines produced by Moderna’s competitors. On this news, the price of Moderna stock fell more than 11%, according to the complaint. ​

False and Misleading Statements:

• The Moderna class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) mRNA-1345 was less effective than defendants had led investors to believe; and (ii) accordingly, mRNA-1345’s clinical and/or commercial prospects were overstated.

THE LEAD PLAINTIFF DEADLINE IN THE CLASS ACTION against Moderna

​Lead plaintiff motions for the Moderna class action lawsuit must be filed with the court no later than October 8, 2024.​ When a securities class action is filed such as the Moderna lawsuit:

1. The person who files the first complaint is required to publish a notice announcing the filing.
2. Anyone who wants to be lead plaintiff on behalf of the class must thereafter file a motion to be appointed as lead plaintiff(s) no later than 60 days after the notice was published. 

THE LEAD PLAINTIFF PROCESS IN THE Moderna LAWSUIT

​​Under the Private Securities Litigation Reform Act of 1995 (PSLRA):

• Any investor who purchased and suffered losses in Moderna stock may seek appointment as lead plaintiff in the Moderna class action lawsuit.
• A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. 
• A lead plaintiff acts on behalf of all other class members in directing the class action lawsuit.
• The lead plaintiff can select a law firm of its choice to litigate the securities class action lawsuit. 
• An investor’s ability to share in any potential future recovery of the class action lawsuit is not dependent upon serving as lead plaintiff. 

ELIGIBILITY CRITERIA FOR LEAD PLAINTIFF APPOINTMENT IN THE Moderna class action LAWSUIT

​​To be eligible for appointment as the lead plaintiff in the Moderna class action lawsuit, an investor must meet the following criteria:

1. Securities Acquisition: The investor must have purchased or acquired Moderna  securities during the Class Period, spanning January 18, 2023, to June 25, 2024,
2. Financial Losses: The investor must have suffered financial losses as a direct result of the alleged securities fraud perpetrated by Moderna and its executives.
3. Typicality and Adequacy: The investor's legal claims must be typical of those asserted on behalf of the class, and they must demonstrate their ability to adequately represent the interests of the entire class through experience, resources, and the absence of conflicts of interest.

It is crucial to note that both domestic and international investors who meet these criteria are eligible to seek appointment as the lead plaintiff in the Moderna class action lawsuit, as courts have consistently recognized the rights of non-U.S. investors in securities class actions.

LEGAL REQUIREMENTS FOR PREVAILING IN THE Moderna CLASS ACTION LAWSUIT

To succeed in the Moderna class action lawsuit, the plaintiffs must establish the following elements:

1. Material Misrepresentation or Omission: The defendants made false or misleading statements or failed to disclose material facts about Moderna's business, operations, or financial condition.
2. Scienter: The defendants acted with the requisite state of mind, such as knowledge or reckless disregard for the truth, when making the alleged misrepresentations or omissions.
3. Connection to Securities Transaction: The alleged misrepresentations or omissions were made in connection with the purchase or sale of Moderna securities.
4. Reliance: Investors relied on the defendants' misrepresentations or omissions when making their investment decisions.
5. Economic Loss: Investors suffered financial losses as a result of the alleged securities fraud.
6. Loss Causation: The defendants' misrepresentations or omissions caused the economic losses suffered by investors.

Establishing these elements is crucial for the plaintiffs to prevail in the Moderna class action lawsuit and recover damages on behalf of the class members.

STAGES OF THE MODERNA CLASS ACTION LAWSUIT

​Securities class action lawsuits like the Moderna class action lawsuit typically follow a multi-stage process, which may include:

1. Consolidation and Lead Plaintiff Appointment: Related cases are consolidated, and the court appoints the lead plaintiff(s) to represent the class.
2. Filing of Consolidated Complaint: The lead plaintiff files a consolidated complaint outlining the allegations against the defendants.
3. Motion to Dismiss: The defendants may file a motion to dismiss the complaint, which the court will consider and rule upon.
4. Class Certification: The court determines whether the case meets the criteria for class certification, allowing it to proceed as a class action.
5. Discovery: Both parties exchange relevant documents and information through the discovery process.
6. Settlement Negotiations and Mediation: The parties may engage in settlement negotiations or mediation to explore the possibility of resolving the case without a trial.
7. Summary Judgment Motions: The parties may file motions for summary judgment, seeking a resolution without a trial based on the undisputed facts.
8. Trial: If the case does not settle, it proceeds to trial, where a judge or jury will determine liability and damages.
9. Appeals: Either party may appeal the court's decisions, potentially extending the litigation timeline.

​The duration of a securities class action lawsuit can vary significantly depending on the complexity of the case and the parties' willingness to engage in settlement negotiations.

CONTINGENCY FEE ARRANGEMENTS AND COST CONSIDERATIONS

Contact Moderna stock loss lawyer Timothy L. Miles about the Moderna class action lawsuit

​​Many securities litigation attorneys, including Timothy L. Miles, operate on a contingency fee basis, which means:

• Clients do not pay any upfront fees or costs.
• Instead, the attorney's fees and expenses are deducted from any settlement or judgment recovered on behalf of the class, typically as a court-approved percentage of the total recovery.
• This arrangement ensures that investors can pursue their legal rights without bearing the financial burden of costly litigation, as the attorneys assume the risk and only receive compensation if they achieve a successful outcome for the class.

---

Frequently Asked Questions

Can I serve as a lead plaintiff in the class action against Moderna if I purchases shares outside of the class period?

​​​​No.  Even if you suffered losses in Moderna ​​​stock, if you purchased securities outside of the Class period, you will not be able to participate in the Moderna class action lawsuit.

Can I serve as a lead plaintiff in the class action against Moderna if I am serving as lead plaintiff in another securities fraud case?

​​​​​​Yes, unless you have been a lead plaintiff in more than five securities class actions during any three-year period which is expressly prohibited by the securities laws. Otherwise, if you suffered losses in Moderna ​ stock, 

Can the court appoint more than one lead plaintiff in the Moderna lawsuit?

​​​​​​Yes, at its discretion the Court may appoint a person, entity, or group of persons and/or entities as Lead Plaintiffs in the Moderna class action lawsuit.

How do I know if I am a member of the class in the class action against Moderna?

​​​​If you purchased shares during the class period and suffered losses in Vicor​ stock, then you are most likely a member of the class in the Moderna class action lawsuit and may participate in the Moderna class action lawsuit since you suffered losses in Moderna stock.

Can I serve as lead plaintiff in the Moderna class action lawsuit if I sold my shares?

​​Yes. There is no requirement for you to retain ownership of the stock after the class period has expired to participate in the Moderna class action lawsuit.

CONTACT Moderna STOCK LOSS LAWYER TODAY TIMOTHY L MILES TODAY ABOUT A Moderna CLASS ACTION LAWSUIT

​​​If you suffered losses in Moderna ​stock, contact Moderna stock loss lawyer Timothy L. Miles today for a free case evaluation about a Moderna class action lawsuit. Call today and see what a Moderna​ ​​stock loss lawyer could do for you if you suffered losses in Moderna ​stock. ​This will most likely be the only call you need to make. (855) 846–6529 or [email protected]. ​

The Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
​300 Centerview Dr., #247
Brentwood, TN 37027
Phone: (855) 846–6529
​​Email: [email protected]

Moderna stock loss lawyer Timothy L. Miles
​

Nashville attorney Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles has dedicated his career to representing shareholders, employees, and consumers in complex class-action litigation. Whether serving as lead, co-lead, or liaison counsel, Mr. Miles has helped recover hundreds of millions of dollars for defrauded investors,  shaped precedent-setting decisions, and delivered real corporate governance reforms. Judges and peers have repeatedly recognized Mr. Miles’ relentless advocacy for the underdog, as well as his unbendable ethical standards. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association,​Class Action:  Class Action: Top National Trial Lawyers, National Trial Lawyers Association (2023), a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019); a Top Rated Litigator by Martindale-Hubbell® and ALM  (2019-2022); America’s Most Honored Lawyers 2020 – Top 1% by America’s Most Honored (2020-2022).  Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, civil procedure, derivative actions, corporate takeover litigation, corporate formation, mass torts, dangerous drugs, and more.  Please visit our website or call for free anytime.
• Top 100 Civil Plaintiff Trial Lawyers by The National Trial Lawyers Association (2017-2022).
• Class Action:  Top 25 National Trial Lawyers by the National Trial Lawyers Association (2023)
• AV® Preeminent™ Attorney by Martindale-Hubbell® (2014-2022).
• AV® Preeminent™ Attorney – Judicial Edition (2017-2022).
• Top Ranked Lawyer by Martindale-Hubbell® and ALM  (2019-2022).
• Top Rated Litigator by Martindale-Hubbell® and ALM  (2019-2022)
• Elite Lawyer of the South by Martindale-Hubbell® and ALM  (2019-2022).
• PRR AV Preeminent Rating on Lawyers.com by Martindale-Hubble® (2018-2022).
• America’s Most Honored Lawyers 2020 – Top 1% by Lawyers of Distinction (2020-2021).
• America’s Most Honored Lawyers 2020 – Top 1% by America’s Most Honored (2020-2022).
• Top 1% of Attorneys in America by Premier Lawyers of America (2019-2021).
• Nation’s Top One Persent by the National Association of Distinguished Counsel (2021).
• The Top-Rated Lawyer in Litigation™ for Ethical Standards and Legal Ability by Martindale-Hubble® (Feb. 2015).
• Distinguished Lawyer, Recognizing Excellence in Securities Law, Lawyers of Distinction (2019-2021)
• Lifetime Achievement Award by Premier Lawyers of America (2019-2021).
• Superb Rated Attorney, (10.0 out of 10), the Highest Rating Possible by Avvo.
• Avvo Top Rated Lawyer (Avvo 2017-2022).
• Avvo Client's Choice Award 2021 (Avvo 2021).
• Elite Lawyer 2021 by Elite Lawyer (2019-2021).
• America’s Most Honored Professionals – Top 1% (American Registry 2016-2022).
• Top Rated Lawyers in Tennessee (Lawyers of Distinction 2021-2022)

CONTACT                                                      
The Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
​300 Centerview Dr., #247
Brentwood, TN 37027
​​Phone:(855) 846-6529
​Email: [email protected]
www.masstortsheadquarters.com